Literature DB >> 11747722

Modeling potential responses to smallpox as a bioterrorist weapon.

M I Meltzer1, I Damon, J W LeDuc, J D Millar.   

Abstract

We constructed a mathematical model to describe the spread of smallpox after a deliberate release of the virus. Assuming 100 persons initially infected and 3 persons infected per infectious person, quarantine alone could stop disease transmission but would require a minimum daily removal rate of 50% of those with overt symptoms. Vaccination would stop the outbreak within 365 days after release only if disease transmission were reduced to <0.85 persons infected per infectious person. A combined vaccination and quarantine campaign could stop an outbreak if a daily quarantine rate of 25% were achieved and vaccination reduced smallpox transmission by > or = 33%. In such a scenario, approximately 4,200 cases would occur and 365 days would be needed to stop the outbreak. Historical data indicate that a median of 2,155 smallpox vaccine doses per case were given to stop outbreaks, implying that a stockpile of 40 million doses should be adequate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747722      PMCID: PMC2631899          DOI: 10.3201/eid0706.010607

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  12 in total

Review 1.  The looming threat of bioterrorism.

Authors:  D A Henderson
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

2.  Impact of population density on immunization programmes.

Authors:  I Arita; J Wickett; F Fenner
Journal:  J Hyg (Lond)       Date:  1986-06

3.  Population biology of infectious diseases: Part I.

Authors:  R M Anderson; R M May
Journal:  Nature       Date:  1979-08-02       Impact factor: 49.962

4.  Routine childhood vaccination against smallpox reconsidered.

Authors:  J M Lane; J D Millar
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

5.  Smallpox in Europe, 1950-1971.

Authors:  T M Mack
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

Review 6.  Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Authors:  D A Henderson; T V Inglesby; J G Bartlett; M S Ascher; E Eitzen; P B Jahrling; J Hauer; M Layton; J McDade; M T Osterholm; T O'Toole; G Parker; T Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  1999-06-09       Impact factor: 56.272

7.  Smallpox: clinical and epidemiologic features.

Authors:  D A Henderson
Journal:  Emerg Infect Dis       Date:  1999 Jul-Aug       Impact factor: 6.883

8.  Aftermath of a hypothetical smallpox disaster.

Authors:  J Bardi
Journal:  Emerg Infect Dis       Date:  1999 Jul-Aug       Impact factor: 6.883

9.  Population biology of infectious diseases: Part II.

Authors:  R M May; R M Anderson
Journal:  Nature       Date:  1979-08-09       Impact factor: 49.962

Review 10.  The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?

Authors:  A F Kaufmann; M I Meltzer; G P Schmid
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

View more
  58 in total

Review 1.  Biological warfare and bioterrorism.

Authors:  Nicholas J Beeching; David A B Dance; Alastair R O Miller; Robert C Spencer
Journal:  BMJ       Date:  2002-02-09

2.  Interim smallpox guidelines for the United Kingdom.

Authors:  Richard Harling; Dilys Morgan; W John Edmunds; Helen Campbell
Journal:  BMJ       Date:  2002-12-14

3.  Knowledge-based bioterrorism surveillance.

Authors:  David L Buckeridge; Justin Graham; Martin J O'Connor; Michael K Choy; Samson W Tu; Mark A Musen
Journal:  Proc AMIA Symp       Date:  2002

4.  Antiviral immunity following smallpox virus infection: a case-control study.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Motomi Mori; Caroline W Koudelka; Mark K Slifka
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

5.  Emergency response to a smallpox attack: the case for mass vaccination.

Authors:  Edward H Kaplan; David L Craft; Lawrence M Wein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-12       Impact factor: 11.205

Review 6.  [Bioterrorism and primary care].

Authors:  M A Mayer Pujadas; M J Alvarez Pasquín; J Gómez Marco; J Redondo Sánchez; J Muñoz Gutiérrez; M Cereceda Ferrés; C Batalla Martínez; E Comín Bertrán; A Pareja Bezares; R Piñeiro Guerrero; V Niño Martín; J Arranz Izquierdo; P Carceller; E Nodar Martín; J Ortega Martínez; J Vázquez Villegas
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

7.  Development of a candidate polyvalent live vaccine against human immunodeficiency, hepatitis B, and orthopox viruses.

Authors:  S N Shchelkunov; A E Nesterov; I A Ryazankin; G M Ignat'ev; L S Sandakhchiev
Journal:  Dokl Biochem Biophys       Date:  2003 May-Jun       Impact factor: 0.788

8.  Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.

Authors:  Megan M McCausland; Mohammed Rafii-El-Idrissi Benhnia; Lindsay Crickard; John Laudenslager; Steven W Granger; Tomoyuki Tahara; Ralph Kubo; Lilia Koriazova; Shinichiro Kato; Shane Crotty
Journal:  Antivir Ther       Date:  2010

9.  Development of the small-molecule antiviral ST-246 as a smallpox therapeutic.

Authors:  Douglas W Grosenbach; Robert Jordan; Dennis E Hruby
Journal:  Future Virol       Date:  2011-05       Impact factor: 1.831

10.  A model curriculum for public health bioterrorism education.

Authors:  Zygmunt Dembek; Anthony Iton; Holger Hansen
Journal:  Public Health Rep       Date:  2005 Jan-Feb       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.